Are you ready to make a difference in the world and become part of our patient-centered team that is focused on Attacking Bladder Cancer for a Better Tomorrow? At CG Oncology, we believe that by having exceptionally talented individuals on our team who share our passion and enjoy working together, we can truly achieve our Vision and Mission to benefit patients around the world.
Every day we are making significant advancements across our multiple pipelines and are growing rapidly to meet the needs of our patients who cannot afford to wait to benefit from our novel immunotherapies. Please review this job posting and our Values and if they resonate with you and are what you expect from your organization and team, then we would like to hear from you.
We invite you to review our website to learn more about our company and team by visiting our website at https://www.cgoncology.com/careers/#overview.
_____________________________________________________________________________________
Role: Senior Director, Health Economics & Outcomes Research (HEOR)Location: Remote US-BasedEssential Functions

• The Senior Director of Health Economics and Outcomes Research (HEOR) at CG Oncology is a pivotal leadership role at CG Oncology responsible for developing and executing the HEOR Evidence Strategy.
• This individual will partner closely with commercial, medical, and cross-functional teams to align evidence and insights generation plans with drug development and commercialization strategies for assigned assets.
• The Senior Director will lead a team of HEOR professionals and collaborate with counterparts in Real-World Evidence (RWE) and Modeling to execute approved studies, ensuring alignment with strategic objectives.
• The Senior Director will drive the incorporation of research findings into customer-facing communication materials and provide HEOR input into policy issues and value assessments.
• This role requires strong HEOR expertise, cross-functional leadership, collaboration skills, and integrity.

Qualifications

• Master’s degree required.
• Minimum of ten (10) years of experience in health economics, outcomes research, pricing, reimbursement, medical affairs, and/or portfolio analysis, with at least 5 years in a leadership role. Previous experience in the pharmaceutical industry, payer, or healthcare sector is highly preferred.
• Deep experience in health economics, outcomes research methodologies, and designing economic studies, including the development of economic models. Track record of peer-reviewed scientific publications and strategic HEOR communication tools development.
• Strong understanding of US healthcare systems, including managed care organizations, integrated health systems, PBMs, Medicare, and Medicaid.
• Excellent written and verbal communication and negotiation skills, with a proven ability to interact effectively with key customers and present materials to drug formularies and other stakeholders.

The U.S. target annual salary range for this remote, full-time, position is currently set at $283,000 - $292,000. The actual base salary offered for this role will vary depending on job-related knowledge, skills, market factors, experience and considering internal equity. In addition, to the base salary, CG Oncology offers a very attractive set of Total Rewards (including bonus and equity) and Well-Being Benefits provided as part of the overall compensation package for this role.
Please visit https://www.cgoncology.com/careers/#rewards for a listing of these rewards and benefits.
Total RewardsCG Oncology offers very competitive and comprehensive Total Rewards, helping to support and reward our global team of high-performing employees focused on developing bladder-saving therapeutics for patients afflicted with bladder cancer.

• HIGHLY COMPETITIVE SALARIES
• ANNUAL PERFORMANCE/MERIT REVIEWS
• ANNUAL PERFORMANCE BONUSES
• EQUITY
• SPECIAL RECOGNITION

Well-Being BenefitsIn addition to our Total Rewards, CG Oncology offers a variety of Well-Being Benefits to the meet the majority of the needs of our unique and growing workforce. These benefits are designed to support our team to achieve a healthy balance between work and their personal lives to remain refreshed, engaged, and creating an environment where each person can find a deeper meaning and purpose in their work.
Well-Being Benefits eligibility begins the 1st of the month after hire. While a majority of these benefits are for our US-based workforce, we continue to assess comparable levels of benefits for our international team members that are aligned with country-specific regulations and their national programs offered.

• FULLY REMOTE WORK ENVIRONMENT
• REST AND RECHARGE - Unlimited Paid Time Off (PTO)
• HOLIDAYS – We observe 12 Holidays/year
• RETIREMENT – 401K with 100% company Safe Harbor match up to 4% of base salary
• HEALTH (MEDICAL, DENTAL, VISION) – HMOs, PPOs & HDHP – Anthem/MetLife
• HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC
• ILLNESS & DISABILITY PROTECTION – Company Paid LTD Coverage Voluntary Plans
• LIFE INSURANCE – Company Paid 1 x base salary Voluntary Plans
• ADDITIONAL EXCLUSIVE BENEFITS – Voluntary Legal, Pet, Plus More

CG Oncology Is An Equal Opportunity EmployerAll applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. At CG Oncology, we are building a community of intelligent and passionate team members that share our Vision, Mission and Values, and while the biotechnology space can feel limited in BIPOC, non-binary and even female representation, we endeavor to make hiring decisions that will continue to grow and support our team in the direction of maintaining cultural diversity and sustainability.
Please note that CG Oncology does not accept unsolicited information and/or resumes from search firms or agencies for our job postings. Any resumes or client information submitted to our careers page or any employee of CG Oncology by any search firm or agency without an applicable contract in place will become the property of CG Oncology and no fee(s) will be paid.